🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT07040189
Recruiting Not applicable

Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders

NCT07040189 · tracked via the Priya Life Science Germany tracker
Phase
Not applicable
Started
2025-11-25
Last updated
2026-08-21

Condition(s) studied

Multiple MyelomaGI CancerTaste Disorders

Investigational drug(s) / intervention(s)

Gustabor server

Gustabor server: AI based web platform providing individual lifestyle tips and recipe recommendations based on the patient's individual data and taste disorder

Study summary

The study investigates taste disorders that commonly occur during or after cancer treatment, often leading to issues such as malnutrition and treatment discontinuation. Although many non-pharmacological recommendations exist, it is unclear which methods are suitable for which individuals. This pilot study aims to use an AI-based, or rule-driven system to generate personalized recommendations based on patients' specific impairments and taste disorder. For the pilot study, the AI will be trained on recipes to create individualized meal plans, helping to identify foods that are likely to be better. The primary endpoint is the assessment of the nutritional intervention as helpful at the second visit within 12 weeks of inclusion.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 18 * Suffering from one of the following tumor entities: Multiple myeloma or malignant tumor of the gastrointestinal tract * Mainly oral nutrition * Subjectively perceived tumor therapy-related taste disorder * At least two clinical presentations planned within 12 weeks with a minimum interval of three weeks * Ability to participate in nutritional intervention, including use of the online portal and implementation of recipe suggestions (e.g. resources and access to a kitchen), either independently or with third-party support (e.g. by relatives, outpatient care services). Exclusion Criteria: * Pregnancy * Taste disorder explained by other causes (e.g. existing before therapy or COVID disease) * Placement in an inpatient care facility

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
LMU Klinikum Munich Bavaria Completed
Universitätsklinikum Regensburg Regensburg Bavaria Recruiting
Universitätsklinikum Würzburg Würzburg Bavaria Recruiting

More Wuerzburg University Hospital trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07040189 on ClinicalTrials.gov ↗ ← All trials in Germany